Sodium‐glucose co‐transporter 2 inhibitor therapy: use in chronic kidney disease and adjunctive sodium restriction

The global burden of chronic kidney disease (CKD) has increased significantly over the past few decades. This reflects the rising prevalence of type 2 diabetes mellitus (T2DM) and hypertension, two leading causes of CKD. Hypertension, which can also be a complication of CKD, accelerates renal diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiwary, Mansi, Milder, Tamara Y., Stocker, Sophie L., Day, Richard O., Greenfield, Jerry R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796501/
https://www.ncbi.nlm.nih.gov/pubmed/35257458
http://dx.doi.org/10.1111/imj.15727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796501/
https://www.ncbi.nlm.nih.gov/pubmed/35257458
http://dx.doi.org/10.1111/imj.15727

Ejemplares similares